Loading...
INDEX: NASDAQ
SYMBOL: ARQL
NAME: ArQule, Inc.
UPVOTES: 62
DOWNVOTES: 62


Description

ArQule, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics to treat cancers and rare diseases. These drugs focuses on the biological pathways implicated in a range of cancers and certain non-oncology indications. Its clinical-stage pipeline consists of over four drug candidates, all of which are in targeted patient populations. The Company's lead product candidate is tivantinib (ARQ 197), an orally administered, small molecule inhibitor of the c-Met receptor tyrosine kinase (MET) and its biological pathway. The Company's product candidates include ARQ 092, designed to inhibit the AKT serine/threonine kinase; ARQ 087, a multi-kinase inhibitor designed to inhibit the fibroblast growth factor receptor (FGFR) family, and ARQ 761, a Beta lapachone analog being evaluated in investigator-sponsored testing as a promoter of NQO1-mediated programmed cancer cell necrosis.

Read Full Descript at Reuters

ARQL Message Board



Todays Most
Up-Voted
Todays Most
Down-Voted
Most
Recent Voted
All Time Most
Up-Voted
All Time Most
Down-Voted
Top
Voted Index

NASDAQ



Stock SymbolUp VotesDown VotesVote
ACB30
ARCB20
AUMN10
AMER21
ALQA10
ADMS10
ACET11
APAFF01
AREX01
AIM01
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661
Stock SymbolUp VotesDown VotesVote
ALIM52
AGNC63
ACB52
ARCB63
TKSTF31
AMDA42
AXS53
ATTBF42
AMER53
ACAD42
Stock SymbolUp VotesDown VotesVote
SDVI189
AGNC126
ARCB1410
AAPL128
ALIM85
ACAD85
A96
QSEP63
AXS108
IPG31
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661

Last 10 Stocks Voted On

Stock SymbolActionVote
ACETUPVOTE
AMERDOWNVOTE
AMERUPVOTE
ACETDOWNVOTE
AGMDOWNVOTE
AETDOWNVOTE
ARCBUPVOTE
ALQAUPVOTE
ARCBUPVOTE
ACBUPVOTE